A Prescription for Anxiety: An Analysis of Three Brand-Name Drug Companies and Delayed Generic Drug Market Entry

Barbara J. Williams

Article PDF: 

This article will examine the statutory framework that promotes generic market entry, the tension between the brand-name drug companies and the generic drug companies, and how this tension has played out in the actions and legal battles of three brand-name drug companies. It will also discuss recent legislation and rule changes that have sought to prevent the brand-name drug companies from “gaming” the system while leveling the playing field for generic drug companies. Recommendations are also made for further ways to improve the existing legal framework.
40 New Eng. L. Rev. 1

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s